Table 4.
Metabolite | HMDB ID | Effect, β (SE) (×10−3) | % of Effect Mediated by BMI | ||
---|---|---|---|---|---|
Direct Effect | Indirect Effect (Mediated by BMIb) | Total Effect | |||
Cholesteryl esters | |||||
C18:2 CE | HMDB00610 | 4.66 (0.79) | 0.52 (0.11) | 5.18 (0.79) | 9.98 |
C18:1 CE | HMDB00918 | 3.02 (0.79) | 0.48 (0.11) | 3.49 (0.79) | 13.68 |
C16:0 CE | HMDB00885 | 2.84 (0.79) | 0.45 (0.10) | 3.29 (0.79) | 13.57 |
C18:3 CE | HMDB10370 | 2.84 (0.81) | −0.14 (0.09) | 2.70 (0.81) | −5.14c |
C22:4 CE | HMDB06729 | 2.69 (1.29) | 0.84 (0.16) | 3.53 (1.28) | 23.89 |
Phospholipids | |||||
C18:2 LPC | HMDB10386 | 4.46 (0.80) | 0.58 (0.12) | 5.04 (0.80) | 11.44 |
C20:5 LPC | HMDB10397 | 3.82 (0.81) | 0.39 (0.10) | 4.22 (0.81) | 9.30 |
C18:1 LPC | HMDB02815 | 3.61 (0.80) | 0.52 (0.11) | 4.13 (0.80) | 12.60 |
C36:4 PC-A | HMDB07983 | 4.48 (0.81) | 0.22 (0.09) | 4.70 (0.81) | 4.76 |
C34:3 PC plasmalogen | HMDB11211 | 3.89 (0.80) | 0.48 (0.11) | 4.37 (0.80) | 11.02 |
C36:3 PC plasmalogen | HMDB11244 | 3.36 (0.79) | 0.57 (0.11) | 3.93 (0.79) | 14.54 |
C36:2 PC plasmalogen | HMDB11243 | 2.90 (0.78) | 0.57 (0.11) | 3.47 (0.78) | 16.42 |
C34:2 PC plasmalogen | HMDB11210 | 2.83 (0.78) | 0.57 (0.11) | 3.40 (0.78) | 16.63 |
C36:0 PC | HMDB08036 | 2.91 (0.81) | 0.18 (0.09) | 3.08 (0.81) | 5.68 |
C18:2 LPE | HMDB11507 | 2.91 (0.70) | 0.22 (0.08) | 3.12 (0.70) | 6.95 |
C18:1 LPE | HMDB11506 | 2.70 (0.71) | 0.22 (0.08) | 2.92 (0.70) | 7.58 |
C38:3 PE plasmalogen | HMDB11384 | 2.75 (0.78) | 0.51 (0.11) | 3.26 (0.78) | 15.78 |
C40:6 PE | HMDB09012 | −2.61 (0.78) | −0.38 (0.10) | −2.99 (0.78) | 12.62c |
C38:2 PE | HMDB08942 | 2.41 (0.81) | 0.35 (0.10) | 2.76 (0.81) | 12.76 |
C34:0 PI | HMDB09805 | 3.83 (0.81) | −0.14 (0.09) | 3.68 (0.81) | −3.88c |
Glycerolipids | |||||
C34:3 DG | HMDB07132 | −2.59 (0.80) | −0.79 (0.13) | −3.39 (0.80) | 23.36 |
C34:2 DG | HMDB07103 | −2.36 (0.79) | −0.84 (0.14) | −3.20 (0.80) | 26.33 |
C32:1 DG | HMDB07099 | −2.23 (0.79) | −0.84 (0.14) | −3.07 (0.79) | 27.40 |
C34:1 DG | HMDB07102 | −2.16 (0.79) | −0.87 (0.14) | −3.03 (0.79) | 28.71 |
C32:0 DG | HMDB07098 | −2.03 (0.79) | −0.84 (0.14) | −2.87 (0.79) | 29.37 |
C50:2 TG | HMDB05377 | −2.31 (0.78) | −0.86 (0.14) | −3.17 (0.79) | 27.18 |
C52:2 TG | HMDB05369 | −2.19 (0.79) | −0.86 (0.14) | −3.05 (0.80) | 28.15 |
C50:3 TG | HMDB05433 | −2.11 (0.79) | −0.81 (0.14) | −2.92 (0.80) | 27.73 |
C50:1 TG | HMDB05360 | −1.91 (0.78) | −0.89 (0.14) | −2.79 (0.79) | 31.74 |
Sphingolipids | |||||
C18 carnitine | HMDB00848 | 1.67 (0.57) | 0.33 (0.07) | 2.00 (0.56) | 16.31 |
Amino acids | |||||
Glycine | HMDB00123 | 1.89 (0.56) | 0.71 (0.11) | 2.60 (0.57) | 27.33 |
Citrulline | HMDB00904 | 1.90 (0.55) | 0.27 (0.07) | 2.16 (0.55) | 12.28 |
Glutamate | HMDB00148 | −1.34 (0.56) | −0.84 (0.12) | −2.19 (0.57) | 38.65 |
Asparagine | HMDB00168 | 1.43 (0.57) | 0.46 (0.09) | 1.89 (0.57) | 24.25 |
Others | |||||
1-Methyladenosine | HMDB03331 | −2.24 (0.56) | −0.77 (0.12) | −3.02 (0.56) | 25.69 |
Creatine | HMDB00064 | −1.60 (0.57) | −0.41 (0.08) | −2.01 (0.57) | 20.31 |
Abbreviations: BMI, body mass index; CE, cholesteryl ester; DG, diglyceride; HMDB, Human Metabolome Database; ID, identification number; LPC, lysophosphatidylcholines; LPE, lysophosphatidylethanolamine; PC, phosphocholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; SE, standard error; TG, triglyceride.
a Linear regression analysis with adjustment for age (years; continuous), case-control status (case, control), case-control study nested within the 3 cohort studies (16 categories), smoking status (never, past, or current smoker), fasting status at blood collection (yes, no), alcohol intake (g/day; continuous), Alternative Healthy Eating Index score (0–100; continuous), total energy intake (kcal/day; continuous), and intakes of fatty acids (linolenic acid, α-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, oleic acid, stearic acid, and trans- fatty acids).
b BMI is calculated as weight (kg)/height (m)2.
c The mediation effect was not significant.